The Structural Heart Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for structural heart devices has seen robust growth recently. It is projected to increase from $10.41 billion in 2024 to $11.44 billion in 2025, representing a compound annual growth rate (CAGR) of 9.9%. The historical growth trend in the Structural Heart Devices market has been positive.
The Structural Heart Devices market is forecasted to reach a valuation of $16.48 billion by 2029, expanding at a Compound Annual Growth Rate (CAGR) of 9.6%.
Download Your Free Sample of the 2025 Structural Heart Devices Market Report and Uncover Key Trends Now!The drivers in the structural heart devices market are:
• Shift towards less invasive surgical techniques
• Demand for minimally invasive structural heart devices
• Ongoing training and education programs for healthcare professionals
• Rising healthcare expenditure and growing patient preference for non-surgical treatments
The structural heart devices market covered in this report is segmented –
1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems
2) By Procedure: Replacement Procedures, Repair Procedures
3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications
4) By Age Group: Pediatric, Adults
The trends in the structural heart devices market are:
• The trend of increasing adoption of transcatheter valve replacement is shaping the future of the structural heart devices market.
• Ongoing development of innovative devices using advanced materials is an emerging trend.
• There is a growing emphasis on personalized treatment approaches in the sphere of structural heart devices.
• Increasing adoption of hybrid procedures, and integration of remote monitoring and telehealth solutions are key emerging trends in this market.
The major players in the structural heart devices market are:
• Abbott Laboratories
• Medtronic Plc
• Boston Scientific Corporation
• Terumo Corporation
• Edwards Lifesciences Corporation
• W L Gore & Associate
North America was the largest region in the structural heart devices market in 2024